What is the anesthetic management for ALCAPA (Anomalous Left Coronary Artery from the Pulmonary Artery) surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Management of ALCAPA Surgery

The optimal anesthetic management for ALCAPA surgery requires a fellowship-trained cardiac anesthesiologist credentialed in perioperative transesophageal echocardiography (TEE) to provide or supervise anesthetic care, with close collaboration between the anesthesiologist and surgeon during critical phases of the procedure. 1, 2

Preoperative Assessment and Preparation

Cardiac Function Evaluation

  • Assess left ventricular function, degree of mitral regurgitation, and extent of myocardial ischemia/fibrosis
  • Review coronary anatomy via CT or MRI angiography to understand the anomalous coronary structure
  • Evaluate collateral circulation from the right coronary artery (critical for survival)
  • Identify high-risk features: severe LV dysfunction, significant mitral regurgitation, ventricular arrhythmias

Preoperative Optimization

  • Continue antiarrhythmic medications perioperatively
  • Consider introducing calcium channel blockers or beta-blockers to reduce arrhythmia risk
  • Formulate a clear anesthetic plan with the surgical team through a formalized checklist-guided multidisciplinary communication

Intraoperative Monitoring

Essential Monitoring

  • Standard ASA monitors
  • Invasive arterial pressure monitoring
  • Central venous pressure monitoring
  • Transesophageal echocardiography (TEE) for real-time assessment of:
    • Ventricular function
    • Regional wall motion
    • Valve function (particularly mitral valve)
    • Coronary reimplantation assessment

Advanced Monitoring

  • Cerebral oxygen saturation monitoring (NIRS) to detect cerebral hypoperfusion
  • Pulmonary artery catheter in high-risk patients (severe LV dysfunction, pulmonary hypertension)

Anesthetic Technique

Induction

  • Etomidate or carefully titrated propofol for induction to maintain hemodynamic stability
  • Avoid pure vasodilators that may compromise coronary perfusion
  • Short-acting opioids for analgesia
  • Consider benzodiazepines for amnesia

Maintenance

  • Volatile anesthetic-based regimen at low concentrations to facilitate early extubation and reduce patient recall 1
  • Opioid supplementation for analgesia
  • Consider dexmedetomidine for its sympatholytic and analgesic properties

Hemodynamic Management

Key Goals

  • Maintain adequate coronary perfusion pressure
  • Avoid tachycardia (shortens diastolic filling time)
  • Maintain normal to slightly elevated systemic vascular resistance
  • Avoid significant increases in pulmonary vascular resistance
  • Target balanced myocardial oxygen supply and demand

Cardiopulmonary Bypass (CPB) Management

  • Close collaboration between anesthesiologist and surgeon during vascular cannulation and weaning from CPB 1
  • Administration of low concentrations of volatile anesthetic via venous oxygenator during CPB
  • Careful monitoring during displacement of the heart and application of stabilizer devices
  • Meticulous attention to hemodynamic alterations during manipulation of the heart and great vessels

Ventilation Strategy

  • Implement lung-protective ventilation (tidal volumes 6-8 mL/kg)
  • Maintain normocapnia to avoid pulmonary vasoconstriction
  • Apply protective one-lung ventilation combining tidal volume 6 mL/kg, PEEP, and alveolar recruitment maneuvers if thoracoscopic approach is used 1

Fluid Management

  • Administer between 2-6 mL/kg/h of baseline intraoperative fluid 1
  • Consider titrating intraoperative fluid management using esophageal Doppler-guided hemodynamic monitoring 1

Post-CPB Management

  • Assess coronary reimplantation with TEE
  • Evaluate for regional wall motion abnormalities
  • Assess mitral valve function (common concomitant issue)
  • Consider inhaled nitric oxide if pulmonary hypertension is present
  • Prepare for potential need for inotropic/vasopressor support

Postoperative Management

Immediate Care

  • Admission to cardiac critical care unit for at least 24 hours
  • Close hemodynamic monitoring
  • Goal-directed fluid therapy
  • Multimodal analgesia to minimize opioid use
  • Early extubation when appropriate
  • Early mobilization as part of enhanced recovery pathway

Analgesia

  • Postoperative locoregional analgesia technique after thoracotomy or thoracoscopy 1
  • Consider continuous paravertebral block rather than thoracic epidural analgesia due to better safety profile 1
  • Short courses of NSAIDs postoperatively (avoid COX-2 inhibitors) 1

Potential Complications and Management

  • Myocardial ischemia: Monitor for ECG changes, regional wall motion abnormalities
  • Arrhythmias: Maintain electrolyte balance, consider antiarrhythmic medications
  • Bleeding: Monitor chest tube output, coagulation parameters
  • Right ventricular dysfunction: Consider inhaled pulmonary vasodilators
  • Mitral regurgitation: Assess with TEE, communicate with surgical team

Long-term Follow-up

  • Clinical evaluation with echocardiography and noninvasive stress testing every 3-5 years 2
  • Monitor for coronary perfusion abnormalities, myocardial function, and valvular function
  • Assess for potential complications: coronary obstruction, stenosis at anastomosis site, residual mitral regurgitation

By following this comprehensive approach to anesthetic management for ALCAPA surgery, the anesthesiologist can optimize patient outcomes while minimizing perioperative risks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioperative Care for Cardiac Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.